viru
famili
arenavirida
consist
one
genu
virus
within
genu
divid
two
differ
group
old
world
arenavirus
new
world
arenavirus
also
known
tacarib
complex
differ
two
group
establish
use
serolog
assay
arenavirus
caus
persist
infect
rodent
without
symptom
human
acquir
varieti
diseas
zoonot
infect
lymphocyt
choriomening
viru
lcmv
arenaviru
exhibit
worldwid
distribut
caus
ill
mening
congenit
lcmv
infect
also
report
importantli
viral
hemorrhag
fever
vhf
caus
sever
arenavirus
lassa
fever
caus
lassa
viru
lasv
old
world
arenaviru
one
devast
vhf
human
hemorrhag
organ
failur
occur
subset
patient
infect
viru
associ
high
mortal
mani
case
lassa
fever
occur
western
africa
countri
guinea
sierra
leon
nigeria
tacarib
complex
lineag
b
new
world
arenavirus
consist
junin
viru
junv
guanarito
viru
gunv
sabia
viru
sabv
machupo
viru
macv
etiolog
agent
argentin
venezuelan
brazilian
bolivian
hemorrhag
fever
respect
although
genet
distinct
one
anoth
appear
produc
similar
symptom
accompani
hemorrhag
human
pathogen
new
world
arenaviru
speci
close
associ
specif
rodent
speci
human
usual
infect
pathogen
arenavirus
direct
contact
tissu
blood
inhal
aerosol
particl
urin
fece
saliva
infect
rodent
incub
period
week
infect
individu
abruptli
develop
fever
retrostern
pain
sore
throat
back
pain
cough
abdomin
pain
vomit
diarrhea
conjunct
facial
swell
proteinuria
mucos
bleed
neurolog
problem
also
describ
includ
hear
loss
tremor
enceph
symptom
pathogen
arenavirusrel
ill
vari
nonspecif
clinic
diagnosi
often
difficult
humantohuman
transmiss
may
occur
via
mucos
cutan
contact
nosocomi
contamin
virus
also
consid
potenti
bioterror
agent
number
arenaviru
speci
recent
discov
result
rodent
survey
diseas
outbreak
novel
pathogen
new
world
arenaviru
chapar
viru
chpv
isol
fatal
case
vhf
bolivia
addit
five
case
vhf
report
south
africa
novel
arenaviru
name
lujo
viru
isol
patient
lujo
viru
distantli
relat
old
world
arenavirus
date
inform
concern
vertebr
host
chapar
lujo
virus
evid
endem
lassa
viru
neighbor
countri
howev
magnitud
intern
trade
travel
continu
increas
perturb
environ
due
either
human
activ
natur
ecolog
chang
may
result
behavior
chang
reservoir
rodent
highli
pathogen
arenavirus
could
introduc
virusfre
countri
endem
area
fact
twenti
case
lassa
fever
report
outsid
endem
region
area
usa
canada
europ
japan
great
import
detect
pathogen
rapidli
specif
order
minim
risk
scale
outbreak
vhf
caus
arenavirus
howev
arenavirus
classifi
biosafeti
level
bsl
pathogen
make
difficult
develop
diagnost
techniqu
viru
infect
laboratori
without
facil
overcom
difficulti
establish
recombin
viral
nucleoprotein
rnp
base
serolog
assay
iggenzymelink
immunosorb
assay
elisa
indirect
immunofluoresc
assay
ifa
antigen
ag
captur
elisa
diagnosi
vhf
caus
highli
pathogen
arenavirus
furthermor
viru
neutral
assay
use
pseudotyp
virusbear
arenaviru
gp
develop
review
describ
use
recombin
proteinbas
diagnost
assay
diagnos
vhf
caus
arenavirus
outbreak
vhf
infect
confirm
variou
laboratori
diagnost
method
viru
detect
perform
viru
isol
revers
transcriptionpolymeras
chain
reaction
rtpcr
antigencaptur
elisa
shown
monoclon
antibodi
panel
pathogen
arenavirus
use
detect
viral
antigen
virusinfect
cell
well
investig
antigen
relationship
arenavirus
detect
viru
genom
suitabl
rapid
sensit
diagnosi
vhf
patient
earli
stage
ill
extens
review
rtpcr
assay
describ
recent
progress
rtpcr
method
cover
genet
variat
hemorrhag
fever
virus
hfv
multiplex
oligonucleotid
microarray
differenti
diagnosi
vhf
also
report
hand
antibodi
virus
detect
indirect
immunofluoresc
assay
ifa
igg
igmelisa
ifa
detect
antibodi
serum
abl
bind
fix
monolay
virusinfect
cell
although
interpret
immunofluoresc
result
requir
experi
assay
advantag
method
sinc
viru
gener
characterist
fluoresc
pattern
add
specif
assay
compar
simpl
elisa
readout
serolog
diagnosi
detect
specif
igm
igg
antibodi
hfv
must
sensit
specif
reliabl
misdiagnosi
lead
panic
gener
popul
igmspecif
elisa
suitabl
detect
recent
infect
relev
igm
test
acut
vhf
depend
viru
durat
ill
specif
igm
often
present
earli
stage
ill
patient
die
vhf
often
fail
seroconvert
iggspecif
elisa
efficaci
diagnosi
larg
number
vhf
case
especi
convalesc
also
epidemiolog
studi
endem
region
detail
method
use
ifa
igg
igmelisa
diagnosi
vhf
use
authent
virusantigen
describ
detail
recombin
baculovirus
express
fulllength
rnp
arenavirus
gener
method
use
purif
arenaviru
rnp
insect
cell
infect
recombin
baculovirus
effect
simpl
compar
ebola
marburg
crimeancongo
hemorrhag
fever
viru
rnp
arenaviru
rnp
express
insect
cell
use
recombin
baculovirus
crystal
solubil
pb
contain
urea
sinc
major
cellular
protein
solubil
pb
contain
urea
arenaviru
rnp
insolubl
fraction
pb
contain
urea
solubil
sonic
pb
contain
urea
simpl
centrifug
lysat
pb
contain
urea
supernat
fraction
use
purifi
rnp
antigen
without
purif
step
control
antigen
produc
cell
infect
baculoviru
lack
polyhedrin
gene
manner
arenaviru
rnp
figur
describ
recombin
baculovirus
allow
deliveri
rnp
antigen
without
use
infecti
live
arenavirus
elisa
plate
coat
predetermin
optim
quantiti
purifi
rnp
approxim
ngwell
use
iggantibodi
detect
assay
advantag
use
recombin
rnp
iggelisa
enabl
direct
comparison
antibodi
crossreact
among
arenaviru
rnp
sinc
antigen
prepar
arenaviru
rnp
test
perform
use
method
rabbit
antisera
rais
lcmvrnp
lasvrnp
show
crossreact
lasvrnp
lcmvrnp
respect
indic
rabbit
antibodi
rnp
old
world
arenavirus
crossreact
rnp
old
world
arenavirus
tabl
similarli
rabbit
antisera
gener
junvnp
show
crossreact
lasvrnp
lcmvrnp
although
reaction
weak
howev
rabbit
antisera
lasvnp
lcmvnp
show
neg
reaction
junvrnp
tabl
indic
rabbit
antibodi
junv
pathogen
new
world
arenaviru
np
might
crossreact
old
world
arenaviru
np
wherea
antibodi
old
world
arenaviru
np
may
abl
react
pathogen
new
world
arenaviru
np
rnpbase
iggelisa
also
use
character
mous
monoclon
antibodi
mab
nakauchi
et
al
investig
crossreact
mab
junv
rnp
pathogen
new
world
arenaviru
rnp
well
lasv
rnp
mab
react
level
rnp
pathogen
new
world
arenavirus
includ
junv
gtov
macv
sabv
chpv
indic
mab
recogn
epitop
conserv
among
pathogen
new
world
arenavirus
anoth
mab
react
specif
rnp
junv
react
pathogen
new
world
arenavirus
indic
mab
recogn
junvspecif
epitop
none
mab
react
rnp
human
pathogen
old
world
arenaviru
lasv
thu
mab
consid
broadli
reactiv
mab
new
world
arenavirus
wherea
mab
junvspecif
find
confirm
detail
epitop
analys
use
peptid
map
similarli
crossreact
mab
lasv
rnp
analyz
mab
crossreact
mopeia
viru
mopv
lcmv
rnp
mab
crossreact
lcmv
rnp
mab
crossreact
lcmv
rnp
import
evalu
whether
rnpbase
elisa
use
diagnosi
human
vhf
case
specif
lasvrnpbas
igg
elisa
confirm
use
sera
obtain
lassa
fever
patient
lassa
fever
patient
sera
show
highli
posit
reaction
lasvrnpbas
iggelisa
sera
patient
argentin
hemorrhag
fever
ahf
caus
junv
serum
ahf
patient
show
highli
posit
reaction
junvrnpbas
iggelisa
addit
shown
use
sera
obtain
ahf
case
result
junv
rnpbase
igg
elisa
correl
well
authent
junv
antigenbas
igg
elisa
igmcaptur
elisa
use
purifi
lasvrnp
antigen
develop
way
previou
report
detect
lasvigm
antibodi
addit
immunoblot
assay
base
ntermin
truncat
lasv
rnp
develop
detect
igg
igm
antibodi
lasv
method
may
provid
rapid
simpl
lassa
fever
test
use
field
condit
ifa
use
virusinfect
cell
common
antibodi
test
vhf
virus
avoid
use
highli
pathogen
virus
antigen
prepar
mammalian
cell
express
recombin
rnp
develop
lassa
viru
np
antigen
ifa
prepar
simpli
describ
briefli
procedur
involv
transfect
hela
cell
mammalian
cell
express
vector
insert
clone
np
cdna
expand
stabl
npexpress
cell
antibiot
select
mix
rnpexpress
cell
untransfect
hela
cell
ratio
spot
cell
mixtur
onto
glass
slide
dri
fix
aceton
ifa
specif
lasvnp
antibodi
posit
sera
show
characterist
granular
stain
pattern
cytoplasm
figur
thu
make
easi
distinguish
posit
neg
sampl
specif
assay
also
confirm
use
sera
obtain
lassa
fever
patient
addit
ifa
use
junv
rnpexpress
hela
cell
develop
detect
antibodi
junv
assay
evalu
use
ahf
patient
sera
lasvrnpbas
antibodi
detect
system
elisa
ifa
suggest
use
diagnosi
lassa
fever
also
seroepidemiolog
studi
lasv
infect
preliminari
studi
approxim
sera
collect
ghanaian
less
zambian
show
posit
reaction
lasvrnpbas
igg
elisa
result
agreement
fact
lassa
fever
endem
west
african
region
includ
ghana
less
east
african
region
diagnosi
mani
viral
infect
pcr
assay
shown
excel
analyt
sensit
establish
techniqu
limit
requir
expens
equip
technic
expertis
moreov
high
degre
genet
variabl
rna
virus
includ
arenaviru
bunyaviru
pose
difficulti
select
primer
rtpcr
assay
detect
strain
viru
sinc
sensit
agcaptur
elisa
compar
rtpcr
sever
virusmedi
infecti
diseas
includ
lassa
fever
filoviru
hemorrhag
fever
agcaptur
elisa
sophist
approach
use
diagnosi
viral
infect
agcaptur
elisa
detect
viral
np
virem
sera
wide
appli
detect
variou
virus
sinc
abund
viral
antigen
highli
conserv
amino
acid
sequenc
polyclon
antisera
mixtur
mab
present
ascet
fluid
anim
immun
hfv
use
captureantibodi
agcaptur
elisa
mab
recogn
conserv
epitop
rnp
also
use
captur
antibodi
sinc
high
specif
antigen
identif
epitop
mab
crucial
import
assess
specif
crossreact
assay
system
order
develop
sensit
diagnost
test
lassa
fever
ahf
rnp
lasv
junv
see
prepar
newli
establish
mab
character
use
agcaptur
elisa
agcaptur
elisa
use
mab
confirm
use
detect
authent
lasv
antigen
sera
serial
collect
hamster
infect
lasv
sensit
mab
agcaptur
elisa
similar
convent
rtpcr
suggest
agcaptur
elisa
effici
use
diagnosi
lassa
fever
therefor
mab
base
agcaptur
elisa
consid
use
diagnosi
lassa
fever
also
use
mab
rais
rnp
junv
agcaptur
elisa
specif
junv
broadli
reactiv
human
pathogen
new
world
arenavirus
develop
agcaptur
elisa
use
mab
detect
ag
pathogen
new
world
arenavirus
test
includ
junv
hand
agcaptur
elisa
use
mab
detect
junv
ag
consid
symptom
junv
infect
human
indistinguish
due
pathogen
new
world
arenavirus
ag
captur
elisa
use
mab
may
use
diagnost
tool
especi
ahf
viru
neutral
assay
accept
gold
standard
serodiagnost
assay
quantifi
antibodi
respons
infect
vaccin
wide
varieti
virus
associ
human
diseas
presenc
neutral
antibodi
reliabl
indic
protect
immun
vhf
direct
method
detect
neutral
antibodi
hfv
plaqu
reduct
neutral
test
use
infecti
virus
howev
high
pathogen
hfv
human
strict
regul
select
agent
limit
number
laboratori
abl
perform
neutral
test
mani
hfv
replicationincompet
pseudotyp
viru
particl
bear
viral
envelop
protein
gp
shown
mimic
respect
hfv
infect
thu
neutral
assay
use
pseudotyp
may
advantag
laboratori
set
detect
antibodi
hfv
without
need
heighten
biocontain
requir
vsvbase
vector
alreadi
use
gener
replicationcompet
recombin
vsv
studi
role
gp
variou
virus
recent
advanc
produc
pseudotyp
viru
particl
enabl
investig
viru
cell
entri
viral
tropism
effect
entri
inhibitor
well
measur
neutral
titer
use
human
immunodefici
viru
felin
immunodefici
viru
murin
leukemia
viru
vsvbase
vector
pseudotyp
base
vsv
advantag
compar
pseudotyp
base
retrovirus
follow
reason
first
pseudotyp
viru
titer
obtain
vsv
system
gener
higher
pseudotyp
retroviru
system
second
infect
target
cell
vsv
pseudotyp
readili
detect
green
fluoresc
protein
gfp
posit
cell
h
postinfect
high
level
gfp
express
vsv
system
contrast
time
requir
infect
pseudotyp
retroviru
system
h
similar
time
requir
infecti
virus
replic
level
result
plaqueform
cytopath
effect
infect
cell
highthroughput
assay
determin
neutral
antibodi
titer
use
vsv
pseudotyp
express
secret
alkalin
phosphatas
luciferas
figur
also
develop
recent
develop
vsvbase
pseudotyp
bear
lassa
viru
gp
vsvlasgp
detect
neutral
antibodi
sera
obtain
lassa
fever
patient
exampl
lasv
neutral
assay
use
vsv
pseudotyp
shown
figur
presenc
serum
lassa
fever
patient
number
gfpposit
cell
infect
vsvlasgp
significantli
reduc
compar
number
absenc
patient
serum
figur
control
vsv
pseudotyp
bear
vsv
gp
vsvvsvg
neutral
sera
serum
dilut
set
inhibit
infect
compar
infect
absenc
test
serum
neutral
titer
patient
serum
vsvlasgp
calcul
figur
likewis
vsvbase
pseudotyp
bear
junin
viru
gp
develop
detect
neutral
antibodi
ahf
patient
sera
accuraci
result
vsvbase
neutral
assay
confirm
comparison
result
neutral
assay
use
live
junin
viru
lujo
viru
new
member
hemorrhag
feverassoci
arenaviru
famili
zambia
southern
africa
viru
classifi
pathogen
genom
sequenc
analysi
lujo
viru
suggest
viru
genet
distinct
previous
character
arenavirus
order
studi
infect
newli
identifi
arenaviru
recent
develop
luciferaseexpress
vsv
pseudotyp
bear
lujo
viru
gpc
vsvlujogp
shown
figur
infect
vsvlujogpc
specif
neutral
rabbit
antilujo
gpc
serum
thu
vsvlujogp
may
use
tool
determin
neutral
antibodi
titer
within
serum
also
explor
yettobedefin
cellular
receptor
lujo
viru
infect
screen
inhibitor
lujo
viru
gpmediat
cell
entri
hemorrhag
fever
outbreak
caus
pathogen
arenavirus
result
high
fatal
rate
rapid
accur
diagnosi
critic
first
step
outbreak
serolog
diagnost
method
vhf
often
employ
elisa
ifa
andor
viru
neutral
assay
diagnost
method
use
recombin
viral
protein
develop
util
diagnos
vhf
review
igg
igm
elisa
ifa
use
rnp
antigen
use
detect
antibodi
induc
patient
sera
method
also
use
seroepidemiolog
survey
hfv
agcaptur
elisa
use
mab
arenaviru
rnp
specif
viru
speci
broadli
reactiv
new
world
arenavirus
depend
mab
use
furthermor
vsvbase
pseudotyp
system
provid
safe
rapid
tool
measur
viru
neutral
antibodi
titer
well
model
analyz
entri
respect
arenaviru
suscept
cell
without
use
live
arenavirus
recent
discoveri
novel
arenaviru
speci
potenti
evolv
predominantli
via
host
switch
rather
host
suggest
unknown
pathogen
arenaviru
may
emerg
futur
diagnost
method
vhf
caus
arenavirus
thu
develop
improv
